Align probiotic goes national
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble's patented probiotic dietary supplement Align reaches store shelves in its nationwide launch, the firm announces May 12. The trademarked bacterial strain in the product, Bifantis, is "clinically proven to help promote the balance of healthy bacteria in the digestive system and to help build and maintain an ongoing natural defense against the five signs of episodic digestive imbalance - constipation, diarrhea, urgency, gas and bloating," the firm says. A 28-count bottle of the once-daily product retails for approximately $30. P&G licenses Bifantis from Irish specialty biotech firm Alimentary Health. P&G holds the trademark and has patent protection until 2020. Marketing initiatives to support the launch include partnering with "celebrity nutritionist" Ashley Koff in an essay contest about consumers' digestive health at 1www.MyDigestiveMakeover.com (2"The Tan Sheet" April 20, 2009, p. 17)
You may also be interested in...
Brands Strain To Stand Out In Probiotic Competition
Major brands are stocking retail shelves with dietary supplements containing probiotic bacteria, but the firms face a growing challenge for making their bacterial strains stand out from the competition
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.